| Article Dump |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Drug Abuse > The Types Of Prescription Drugs Commonly Abused |
|
Article Dump - The Types Of Prescription Drugs Commonly Abused
Prescription drug abuse is a serious issue that has resulted in a number of deaths and criminal activity. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product As a result of the growing trend in prescription drug abuse, pharmacies and doctors have had to take ex ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in tra precautions when issuing prescriptions for certain types of medications. Unfortunately, this has mad lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e it more difficult for those that truly need the medication to meet their health needs. Although nearly here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe every type of prescription drug is likely to be abused in one way or another, there are some types of pr d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro escription drugs that are abused more frequently than others. These include opioids, central nervous sys ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc tem depressants, and stimulants. Opioids Opiods are medications such as oxycodone, hydrocodone, and mep easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi idine. These medications are better known by the commercial names of OxyContin, Vicodin, and Demerol. T nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hese medications are meanth to help relieve pain, coughs, and diarrhea. Those that abuse these medicatio and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ns, however, do so in order to escape reality by preventing the brain from receiving pain messages. As a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi result, those who abuse opioids experience a “high” feeling similar to other illegal drugs. Central Ner ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a vous System Depressants Central nervous system depressants are drugs such as pentobarbital sodium, diaze dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod pam, and alprazolam, better known as Nembutal, Valium, and Xanax, respectively. These medications are us cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ed to treat those suffering from tension, anxiety, sleep disorders, and panic attacks. Those who abuse t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ese drugs do so because of the calming effect they create. Stimulants Examples of stimulants that are c t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ommonly abused include methylphenidate, amphetamine/dextroamphetamine, and atomoxetine. These drugs are ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust better known as Ritalin, Adderrall, and Straterra. These prescription drugs are used to treat ADHD, narc y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products olepsy, obesity, depression, and asthma. Those who abuse them do so in order to increase their attention . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de span, alertness, and energy levels. For these reasons, stimulants are most commonly abused by people lo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip oking to lose weight or by college students wanting to pull an “all nighter” in order to study for a test tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Sales Recruiting: Hire A Racehorse How A Firewall Protects Your Computer On The Internet Secured Personal Loans - Equity Decides The Loan Amount
|